Drug Price Trends for GS CHILD ALL DAY ALLER

Average Pharmacy Cost for GS CHILD ALL DAY ALLER

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
GS CHILD ALL DAY ALLER 1 MG/ML	00113-0189-26	0.03525	ML	2024-12-18
GS CHILD ALL DAY ALLER 1 MG/ML	00113-0503-26	0.03525	ML	2024-12-18
GS CHILD ALL DAY ALLER 1 MG/ML	00113-0189-26	0.02927	ML	2024-11-20
GS CHILD ALL DAY ALLER 1 MG/ML	00113-0503-26	0.02927	ML	2024-11-20

Market Analysis and Price Projections for GS CHILD ALL DAY ALLERGY

Introduction to GS CHILD ALL DAY ALLERGY

GS CHILD ALL DAY ALLERGY, commonly known by its active ingredient cetirizine, is an antihistamine used to treat allergic conditions such as allergic rhinitis and urticaria. This medication is widely available in various forms, including oral tablets and syrup, and is a staple in the allergy treatment market.

Global Allergy Treatment Market Overview

The global allergy treatment market is experiencing significant growth, driven by several key factors. Here are some key points:

• Market Size: The global allergy treatment market was valued at USD 19.07 billion in 2021 and is expected to reach USD 31.63 billion by 2029, registering a CAGR of 6.53% during the forecast period of 2022 to 2029[1].
• Market Drivers: The rising prevalence of various forms of allergies, increasing healthcare expenditure, and the growing number of geriatric populations are significant factors driving the market's growth[1].

Market Segmentation

The allergy treatment market is segmented based on several criteria:

• Type: Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis, and Others[1].
• Treatment: Anti-Allergy Drugs and Immunotherapy[1].
• Route of Administration: Oral, Inhalation, Intranasal, and Others[1].
• End-Users: Hospitals, Specialty Clinics, Homecare, and Others[1].
• Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and Others[1].

Therapeutics Segment

The therapeutics segment, which includes medications like GS CHILD ALL DAY ALLERGY, holds the largest revenue share in the market. This segment dominated the market in 2023 with over 81.67% of the revenue share due to the effectiveness of these medications in alleviating symptoms and providing relief from allergies[3].

Price Analysis of GS CHILD ALL DAY ALLERGY

The cost of GS CHILD ALL DAY ALLERGY varies based on the form and quantity of the medication.

Oral Liquid

• The cost for GS CHILD ALL DAY ALLERGY oral liquid is around $14 for a supply of 118 milliliters, with a per-unit price ranging from $0.12 to $0.13[2][3].

Quantity and Price Breakdown

• 118 milliliters: $14.14 - $15.12
• 120 milliliters: $14.64[2].

Generic and Discount Options

• Generic versions of cetirizine, the active ingredient in GS CHILD ALL DAY ALLERGY, are available. For example, generic cetirizine prices start from $8.80 for 6 tablets, significantly reducing the cost[2][3].

Regional Market Dynamics

The allergy treatment market is geographically diverse, with different regions contributing to its growth.

• North America and Asia-Pacific: These regions are expected to grow significantly during the forecast period due to increasing awareness about allergic diseases, development of healthcare infrastructure, and rising levels of disposable income[1][3].

Market Drivers

Several factors are driving the growth of the allergy treatment market:

• Increasing Prevalence of Allergies: According to a research published in 2020, 32 million Americans suffered from food allergies, including 5.6 million children under the age of 18. This rising prevalence is a significant driver for the market[1].
• Advancements in Diagnostic and Therapeutic Techniques: Personalized allergy forecasts and symptom tracking tools are becoming more prevalent, enhancing patient care and treatment optimization[3].
• Increasing Healthcare Expenditure: Rising healthcare expenditure helps in improving healthcare infrastructure, which further influences the market dynamics[1].

Competitive Landscape

The competitive landscape of the allergy treatment market includes various major players. The market share analysis indicates a competitive environment with both global and local brands vying for market share.

• Government Initiatives: Various government organizations aim to improve healthcare infrastructure by increasing funding, which further influences the market dynamics[1].

Recent Developments

Recent developments in the market include regulatory approvals and product launches.

• FDA Approvals: For example, in July 2020, Alcon announced the FDA approval of the OTC switch of Pataday once daily relief extra strength, which is the first and only eye allergy itch drop available in the United States that provides full 24-hour relief without a prescription[1].

Patient Assistance and Copay Programs

Patient assistance programs (PAPs) and copay programs are available for some medications, although specific programs for GS CHILD ALL DAY ALLERGY may be limited.

• Discount Cards: The Drugs.com Discount Card can save consumers up to 80% or more off the cost of prescription medicines, including allergy treatments[2].

Key Takeaways

• Market Growth: The global allergy treatment market is projected to grow significantly, driven by the increasing prevalence of allergies and advancements in diagnostic and therapeutic techniques.
• Therapeutics Dominance: The therapeutics segment, including medications like GS CHILD ALL DAY ALLERGY, dominates the market due to its effectiveness in treating allergic conditions.
• Generic and Discount Options: Generic versions and discount options can significantly reduce the cost of GS CHILD ALL DAY ALLERGY.
• Regional Dynamics: North America and the Asia-Pacific region play a crucial role in market growth due to increasing awareness and improving healthcare infrastructure.

FAQs

1. What is the current market size of the global allergy treatment market?

• The global allergy treatment market was valued at USD 19.07 billion in 2021 and is expected to reach USD 31.63 billion by 2029[1].

2. What is the projected growth rate of the allergy treatment market?

• The market is projected to grow at a CAGR of 6.53% from 2022 to 2029[1].

3. What are the key factors driving the growth of the allergy treatment market?

• Key factors include the rising prevalence of allergy disorders, increasing healthcare expenditure, and the growing number of geriatric populations[1].

4. How much does GS CHILD ALL DAY ALLERGY typically cost?

• The cost for GS CHILD ALL DAY ALLERGY oral liquid is around $14 for a supply of 118 milliliters, with prices varying based on quantity and pharmacy[2][3].

5. Are there generic versions of GS CHILD ALL DAY ALLERGY available?

• Yes, generic versions of cetirizine are available, starting from $8.80 for 6 tablets[2][3].

Sources

1. Data Bridge Market Research: Global Allergy Treatment Market Growth Drivers, & Trends By 2029.
2. Drugs.com: All Day Allergy Children's Prices, Coupons, Copay Cards & Patient Assistance.
3. DrugPatentWatch: Market Analysis and Financial Projection for ALL DAY ALLERGY.
4. Food Allergy Research and Education Foundation: New Research Shows One-in-Four American Consumers Do Not Purchase Products Containing Top 9 Allergens.
5. Congress.gov: Improving Accountability and Quality of Care at the Indian Health Service.